NCT00015288View on ClinicalTrials.gov

Buprenorphine and Naloxone Combination Study - 10

PHASE1CompletedINTERVENTIONAL

0

Timeline

Start Date

November 30, 1996

Conditions

Heroin DependenceOpioid-Related Disorders

Interventions

DRUG

Buprenorphine/naloxone

Trial Locations (1)

10010

New York MDRU, New York

All Listed Sponsors

collaborator

New York MDRU

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00015288 - Buprenorphine and Naloxone Combination Study - 10 | Biotech Hunter | Biotech Hunter